You are using an outdated browser. Please upgrade your browser to improve your experience.

Marfan syndrome

Disease Summary
Associated Targets (32)
Tbio

19

Tchem

12

Tclin

1


GARD Rare
Mondo Description A disorder of the connective tissue. Connective tissue provides strength and flexibility to structures throughout the body such as bones, ligaments, muscles, walls of blood vessels, and heart valves. Marfan syndrome affects most organs and tissues, especially the skeleton, lungs, eyes, heart, and the large blood vessel that distributes blood from the heart to the rest of the body (the aorta). It is caused by mutations in the FBN1 gene, which provides instructions for making a protein called fibrillin-1. Marfan syndrome is inherited in an autosomal dominant pattern. At least 25% of cases are due to a new (de novo) mutation. Treatment is based on the signs and symptoms in each person.
Uniprot Description A hereditary disorder of connective tissue that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with Marfan syndrome, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in most of the patients and is almost always bilateral. The leading cause of premature death is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Neonatal Marfan syndrome is the most severe form resulting in death from cardiorespiratory failure in the first few years of life.
Disease Ontology Description A connective tissue disease that is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and subluxation of the lens.
Mondo Term and Equivalent IDs
MONDO:0007947:  Marfan syndrome
COHD:258540: 
GARD:0006975: 
ICD9:759.82: 
MESH:D008382: 
NCIT:C34807: 
Orphanet:284963: 
Orphanet:558: 
SCTID:19346006: 
UMLS:C0024796: 
UMLS:CN202883: